Gilead Sciences, Inc. v. Lupin Ltd. et al

  1. October 06, 2025

    Gilead Gets HIV Generic Drugs Barred From Market Until 2036

    Gilead Sciences Inc. said Monday it is keeping generic forms of its HIV treatment Biktarvy off of the market until 2036 following a series of settlements with competitors.

  2. September 02, 2025

    Gilead Rival Agrees Not To Sell Generic HIV Drug For Now

    A Gilead Sciences Inc. competitor has agreed not to sell a generic version of Gilead's human immunodeficiency virus treatment Biktarvy until a trio of patents expire, according to a proposal by the parties to end infringement allegations.

  3. May 10, 2022

    Gilead Slaps Rivals With Patent Suit Over HIV Drug

    Gilead Sciences Inc. has initiated a drug patent suit against a trio of competitors in Delaware federal court, seeking to block three generic versions of its human immunodeficiency virus treatment Biktarvy.